These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8748879)

  • 1. A super long-acting LH-RH analogue induces regression of hypothalamic hamartoma associated with precocious puberty.
    Harada K; Yoshida J; Wakabayashi T; Okabe H; Sugita K
    Acta Neurochir (Wien); 1995; 137(1-2):102-5. PubMed ID: 8748879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.
    Tanaka T; Hibi I; Kato K; Saito S; Shimizu N; Suwa S; Nakajima H
    Endocrinol Jpn; 1991 Aug; 38(4):369-76. PubMed ID: 1839379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central precocious puberty due to hypothalamic hamartoma in a 7-month-old infant girl.
    Rousso IH; Kourti M; Papandreou D; Tragiannidis A; Athanasiadou F
    Eur J Pediatr; 2008 May; 167(5):583-5. PubMed ID: 17541635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot.
    de Brito VN; Latronico AC; Arnhold IJ; Lo LS; Domenice S; Albano MC; Fragoso MC; Mendonca BB
    Arch Dis Child; 1999 Mar; 80(3):231-4. PubMed ID: 10325702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precocious puberty and hypothalamic hamartoma: treatment with triptorelin during eight years].
    Chamouilli JM; Razafimahefa B; Pierron H
    Arch Pediatr; 1995 May; 2(5):438-41. PubMed ID: 7640735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year-old male with accelerated growth and development.
    Kashyap AS; Anand KP; Kashyap S; Arora S
    Postgrad Med J; 2007 Oct; 83(984):e4. PubMed ID: 17916866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot leuprolide acetate for treatment of precocious puberty.
    Parker KL; Lee PA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):689-91. PubMed ID: 2503536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
    Klein KO; Freire A; Gryngarten MG; Kletter GB; Benson M; Miller BS; Dajani TS; Eugster EA; Mauras N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3660-71. PubMed ID: 32738042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of hypothalamic seizures and precocious puberty with GnRH analogue.
    Zaatreh M; Tennison M; Greenwood RS
    Neurology; 2000 Dec; 55(12):1908-10. PubMed ID: 11134395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma.
    Uriarte MM; Klein KO; Barnes KM; Pescovitz OH; Loriaux DL; Cutler GB
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):363-8. PubMed ID: 9861328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of hypothalamic hamartoma causing central precocious puberty: long-term follow-up.
    Li CD; Luo SQ; Gong J; Ma ZY; Jia G; Zhang YQ; Li JF
    J Neurosurg Pediatr; 2013 Aug; 12(2):151-4. PubMed ID: 23746126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypothalamic hamartoma with precocious puberty--a case report].
    Date I; Yagyu Y; Mino S; Ohhashi T
    No Shinkei Geka; 1985 Jun; 13(6):633-8. PubMed ID: 3900784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma.
    Arita K; Ikawa F; Kurisu K; Sumida M; Harada K; Uozumi T; Monden S; Yoshida J; Nishi Y
    J Neurosurg; 1999 Aug; 91(2):212-20. PubMed ID: 10433309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.